- Home
- UONEK vs CVKD Comparison
UONEK vs CVKD Comparison
Compare UONEK & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- CVKD
- Stock Information
- Founded
- UONEK 1980
- CVKD 2022
- Country
- UONEK United States
- CVKD United States
- Employees
- UONEK N/A
- CVKD N/A
- Industry
- UONEK Broadcasting
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- UONEK Consumer Discretionary
- CVKD Health Care
- Exchange
- UONEK Nasdaq
- CVKD Nasdaq
- Market Cap
- UONEK 31.6M
- CVKD 29.5M
- IPO Year
- UONEK N/A
- CVKD 2023
- Fundamental
- Price
- UONEK $0.60
- CVKD $13.18
- Analyst Decision
- UONEK
- CVKD Strong Buy
- Analyst Count
- UONEK 0
- CVKD 1
- Target Price
- UONEK N/A
- CVKD $32.00
- AVG Volume (30 Days)
- UONEK 169.6K
- CVKD 34.8K
- Earning Date
- UONEK 08-07-2025
- CVKD 08-06-2025
- Dividend Yield
- UONEK N/A
- CVKD N/A
- EPS Growth
- UONEK N/A
- CVKD N/A
- EPS
- UONEK N/A
- CVKD N/A
- Revenue
- UONEK $437,499,000.00
- CVKD N/A
- Revenue This Year
- UONEK N/A
- CVKD N/A
- Revenue Next Year
- UONEK N/A
- CVKD N/A
- P/E Ratio
- UONEK N/A
- CVKD N/A
- Revenue Growth
- UONEK N/A
- CVKD N/A
- 52 Week Low
- UONEK $0.44
- CVKD $5.70
- 52 Week High
- UONEK $1.57
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- UONEK 44.92
- CVKD 51.34
- Support Level
- UONEK $0.56
- CVKD $11.00
- Resistance Level
- UONEK $1.40
- CVKD $13.56
- Average True Range (ATR)
- UONEK 0.12
- CVKD 1.11
- MACD
- UONEK -0.01
- CVKD 0.26
- Stochastic Oscillator
- UONEK 4.56
- CVKD 85.72
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.